FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160135935> ?p ?o ?g. }

• W2160135935 endingPage "824.e1" @default.
• W2160135935 startingPage "816" @default.
• W2160135935 abstract "Purpose To evaluate retinal sensitivity in the macular area after intravitreal injection of bevacizumab in eyes with myopic choroidal neovascularization (mCNV). Design Prospective interventional case series. Methods Twenty-two eyes of 21 patients with mCNV were treated with intravitreal injections of bevacizumab. Microperimetry in the macular area was performed with a Micro Perimeter-1 (Nidek, Vigonza, Italy) before, and at 1 month and 6 months after treatment. Results After treatment, visual acuity (VA) and central retinal sensitivity were improved significantly. Mean VA in logarithm of the minimal angle of resolution (logMAR) fashion improved from 0.67 ± 0.34 to 0.43 ± 0.33 at 1 month, and to 0.34 ± 0.26 at 6 months [P < .01, respectively]. Mean retinal sensitivity within the central 10 degrees field improved from 4.8 ± 2.8 decibels (dB) to 6.5 ± 3.2 dB at 1 month and to 7.4 ± 4.4 dB at 6 months [P < .01, respectively]. These improvements were more prominent in eyes with juxtafoveal mCNV than in eyes with subfoveal mCNV. With treatment, the mean number of measurement points within the scotomas decreased significantly; the absolute scotoma was reduced substantially in 15 (68%) eyes at 6 months. Unfortunately, the absolute scotoma was significantly enlarged in 1 eye (5%) at 1 month and in 4 eyes (18%) at 6 months. Also at 6 months, chorioretinal atrophy had developed in the macular area in 4 eyes (18%). Conclusions Although intravitreal injection of bevacizumab improved retinal sensitivity in the macular area, some eyes showed enlargement of the scotoma after this treatment. To evaluate retinal sensitivity in the macular area after intravitreal injection of bevacizumab in eyes with myopic choroidal neovascularization (mCNV). Prospective interventional case series. Twenty-two eyes of 21 patients with mCNV were treated with intravitreal injections of bevacizumab. Microperimetry in the macular area was performed with a Micro Perimeter-1 (Nidek, Vigonza, Italy) before, and at 1 month and 6 months after treatment. After treatment, visual acuity (VA) and central retinal sensitivity were improved significantly. Mean VA in logarithm of the minimal angle of resolution (logMAR) fashion improved from 0.67 ± 0.34 to 0.43 ± 0.33 at 1 month, and to 0.34 ± 0.26 at 6 months [P < .01, respectively]. Mean retinal sensitivity within the central 10 degrees field improved from 4.8 ± 2.8 decibels (dB) to 6.5 ± 3.2 dB at 1 month and to 7.4 ± 4.4 dB at 6 months [P < .01, respectively]. These improvements were more prominent in eyes with juxtafoveal mCNV than in eyes with subfoveal mCNV. With treatment, the mean number of measurement points within the scotomas decreased significantly; the absolute scotoma was reduced substantially in 15 (68%) eyes at 6 months. Unfortunately, the absolute scotoma was significantly enlarged in 1 eye (5%) at 1 month and in 4 eyes (18%) at 6 months. Also at 6 months, chorioretinal atrophy had developed in the macular area in 4 eyes (18%). Although intravitreal injection of bevacizumab improved retinal sensitivity in the macular area, some eyes showed enlargement of the scotoma after this treatment." @default.
• W2160135935 created "2016-06-24" @default.
• W2160135935 creator A5049463882 @default.
• W2160135935 creator A5053086183 @default.
• W2160135935 creator A5055321562 @default.
• W2160135935 creator A5071690549 @default.
• W2160135935 creator A5072525934 @default.
• W2160135935 creator A5086219366 @default.
• W2160135935 creator A5087488592 @default.
• W2160135935 creator A5087692428 @default.
• W2160135935 date "2009-05-01" @default.
• W2160135935 modified "2023-10-18" @default.
• W2160135935 title "Central Retinal Sensitivity After Intravitreal Injection of Bevacizumab for Myopic Choroidal Neovascularization" @default.
• W2160135935 cites W110906275 @default.
• W2160135935 cites W115342157 @default.
• W2160135935 cites W1961426734 @default.
• W2160135935 cites W1968609549 @default.
• W2160135935 cites W1976796315 @default.
• W2160135935 cites W1980777779 @default.
• W2160135935 cites W1983108118 @default.
• W2160135935 cites W1991064811 @default.
• W2160135935 cites W1998819970 @default.
• W2160135935 cites W2015446470 @default.
• W2160135935 cites W2016068843 @default.
• W2160135935 cites W2023874692 @default.
• W2160135935 cites W2051258987 @default.
• W2160135935 cites W2053386201 @default.
• W2160135935 cites W2069895573 @default.
• W2160135935 cites W2077985567 @default.
• W2160135935 cites W2080591818 @default.
• W2160135935 cites W2082556917 @default.
• W2160135935 cites W2086452924 @default.
• W2160135935 cites W2116554707 @default.
• W2160135935 cites W2122595579 @default.
• W2160135935 cites W2155905635 @default.
• W2160135935 cites W2748001554 @default.
• W2160135935 cites W4245313820 @default.
• W2160135935 cites W4361866471 @default.
• W2160135935 doi "https://doi.org/10.1016/j.ajo.2008.11.020" @default.
• W2160135935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19211092" @default.
• W2160135935 hasPublicationYear "2009" @default.
• W2160135935 type Work @default.
• W2160135935 sameAs 2160135935 @default.
• W2160135935 citedByCount "35" @default.
• W2160135935 countsByYear W21601359352012 @default.
• W2160135935 countsByYear W21601359352013 @default.
• W2160135935 countsByYear W21601359352014 @default.
• W2160135935 countsByYear W21601359352015 @default.
• W2160135935 countsByYear W21601359352016 @default.
• W2160135935 countsByYear W21601359352017 @default.
• W2160135935 countsByYear W21601359352019 @default.
• W2160135935 countsByYear W21601359352021 @default.
• W2160135935 crossrefType "journal-article" @default.
• W2160135935 hasAuthorship W2160135935A5049463882 @default.
• W2160135935 hasAuthorship W2160135935A5053086183 @default.
• W2160135935 hasAuthorship W2160135935A5055321562 @default.
• W2160135935 hasAuthorship W2160135935A5071690549 @default.
• W2160135935 hasAuthorship W2160135935A5072525934 @default.
• W2160135935 hasAuthorship W2160135935A5086219366 @default.
• W2160135935 hasAuthorship W2160135935A5087488592 @default.
• W2160135935 hasAuthorship W2160135935A5087692428 @default.
• W2160135935 hasConcept C118487528 @default.
• W2160135935 hasConcept C119767625 @default.
• W2160135935 hasConcept C120665830 @default.
• W2160135935 hasConcept C121332964 @default.
• W2160135935 hasConcept C141071460 @default.
• W2160135935 hasConcept C2776694085 @default.
• W2160135935 hasConcept C2777802072 @default.
• W2160135935 hasConcept C2778257484 @default.
• W2160135935 hasConcept C2779100554 @default.
• W2160135935 hasConcept C2780827179 @default.
• W2160135935 hasConcept C2781359195 @default.
• W2160135935 hasConcept C64731932 @default.
• W2160135935 hasConcept C71924100 @default.
• W2160135935 hasConceptScore W2160135935C118487528 @default.
• W2160135935 hasConceptScore W2160135935C119767625 @default.
• W2160135935 hasConceptScore W2160135935C120665830 @default.
• W2160135935 hasConceptScore W2160135935C121332964 @default.
• W2160135935 hasConceptScore W2160135935C141071460 @default.
• W2160135935 hasConceptScore W2160135935C2776694085 @default.
• W2160135935 hasConceptScore W2160135935C2777802072 @default.
• W2160135935 hasConceptScore W2160135935C2778257484 @default.
• W2160135935 hasConceptScore W2160135935C2779100554 @default.
• W2160135935 hasConceptScore W2160135935C2780827179 @default.
• W2160135935 hasConceptScore W2160135935C2781359195 @default.
• W2160135935 hasConceptScore W2160135935C64731932 @default.
• W2160135935 hasConceptScore W2160135935C71924100 @default.
• W2160135935 hasIssue "5" @default.
• W2160135935 hasLocation W21601359351 @default.
• W2160135935 hasLocation W21601359352 @default.
• W2160135935 hasOpenAccess W2160135935 @default.
• W2160135935 hasPrimaryLocation W21601359351 @default.
• W2160135935 hasRelatedWork W1764554573 @default.
• W2160135935 hasRelatedWork W1993747607 @default.
• W2160135935 hasRelatedWork W2013771446 @default.
• W2160135935 hasRelatedWork W2023516579 @default.
• W2160135935 hasRelatedWork W2036214396 @default.
• W2160135935 hasRelatedWork W2036634700 @default.

• next